Lexaria Bioscience Corp (LEXX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.72
• Market Cap: $17.32M
• EPS: $-0.57
• 52-Week High: $1.90
• 52-Week Low: $0.46

Market Sentiment

Lexaria Bioscience Corp currently has a Bearish sentiment score of -0.19.

About Lexaria Bioscience Corp

Lexaria Bioscience Corp. is a pioneering biotechnology firm headquartered in Kelowna, Canada, specializing in the enhancement of health benefits associated with CBD through its proprietary DehydraTECH™ drug delivery technology. This patented innovation significantly improves the bioavailability of active pharmaceutical ingredients, establishing Lexaria as a leader in the rapidly evolving cannabinoid sector. Committed to extensive research and development, the company seeks to optimize cannabi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Lexaria Bioscience Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LEXX pay dividends?

Lexaria Bioscience Corp (LEXX) does not currently pay a regular dividend.

What is LEXX's market cap?

Lexaria Bioscience Corp (LEXX) has a market capitalization of $17.32M with a current stock price of $0.72.